Terms ending in 2035
Every in-force patent on NuVasive, Inc.'s record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,730,802 | Spinal Fusion Implant and Related Methods In force · High confidence | NuVasive, Inc. | In force | High confidence | |
| US 11,571,247 | Spinal Alignment Frame In force · High confidence | NuVasive, Inc. | In force | High confidence | |
| US 12,127,948 | System for Implanting a Spinal Fusion Implant and Related Methods In force · Medium confidence | NuVasive, Inc. | In force | Medium confidence | |
| US 11,772,306 | Method for Producing Porous Devices In force · Medium confidence | NuVasive, Inc. | In force | Medium confidence | |
| US 12,150,864 | Expandable Intervertebral Implant and Methods of Use Thereof In force · Medium confidence | NuVasive, Inc. | In force | Medium confidence | |
| US 9,788,971 | Expandable Fusion Implant and Related Methods In force · High confidence | NuVasive, Inc. | In force | High confidence | |
| US 9,770,341 | Magnetic Spinal Implant In force · Medium confidence | NuVasive, Inc. | In force | Medium confidence | |
| US 12,653,690 | System for Implanting a Spinal Fusion Implant and Related Methods In force · Medium confidence | NuVasive, Inc. | In force | Medium confidence | |
| US 10,758,274 | Spinal Fixation Constructs and Related Methods In force · High confidence | NuVasive, Inc. | In force | High confidence | |
| US 9,801,734 | Lordotic Expandable Interbody Implant In force · High confidence | NuVasive, Inc. | In force | High confidence | |
| 26 more term ends in 2035 · Pro | |||||
10 of 36 patents shown. Soonest term end first, then patent number.
Pro members see all 36.
34 of these are in force and held by NuVasive, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.